India, April 23 -- West Pharmaceutical Services Inc. (WST), while reporting higher first-quarter earnings and sales, on Thursday issued positive second-quarter outlook, and lifted fiscal 2026 view.
In pre-market activity, the shares were gaining around 18.1 percent, trading at $324.00.
Looking ahead for the second quarter, the company projects adjusted earnings per share in the range of $2.05 to $2.12, up 11.4 percent to 15.2 percent from last year. Net sales are expected to be $830 million to $850 million, a growth of 8.3 percent to 10.9 percent year-over-year. Organic net sales growth is expected to be in the range of 7.0 percent to 9.6 percent.
Further, for fiscal 2026, West Pharma now projects adjusted earnings per share in the range...